share_log

長江生命科技：董事會召開日期

CKLIFE SCIENCES: Date of Board Meeting

HKEX ·  Aug 1, 2024 17:31

Summary by Moomoo AI

長江生命科技集團有限公司宣佈，將於2024年8月13日（星期二）在香港召開董事會會議。會議的主要議程包括批准發布截至2024年6月30日止六個月的中期業績報告，以及考慮是否派發中期股息。目前，公司的執行董事包括李澤鉅先生（主席）、甘慶林先生、葉德銓先生、余英才先生及杜健明醫生；非執行董事則包括Peter Peace Tulloch先生、郭李綺華女士（獨立非執行董事）、關啟昌先生（獨立非執行董事）、Paul Joseph Tighe先生（獨立非執行董事）及羅弼士先生（獨立非執行董事）。
長江生命科技集團有限公司宣佈，將於2024年8月13日（星期二）在香港召開董事會會議。會議的主要議程包括批准發布截至2024年6月30日止六個月的中期業績報告，以及考慮是否派發中期股息。目前，公司的執行董事包括李澤鉅先生（主席）、甘慶林先生、葉德銓先生、余英才先生及杜健明醫生；非執行董事則包括Peter Peace Tulloch先生、郭李綺華女士（獨立非執行董事）、關啟昌先生（獨立非執行董事）、Paul Joseph Tighe先生（獨立非執行董事）及羅弼士先生（獨立非執行董事）。
CKLife Sciences Group will hold a board of directors meeting in Hong Kong on Tuesday, August 13, 2024. The main agenda of the meeting includes approving the release of the interim performance report for the six months ending June 30, 2024, and considering the distribution of interim dividends. The company's executive directors include Mr. Li Zeju (Chairman), Mr. Gan Qinglin, Mr. Ye Dequan, Mr. Yu Yingcai, and Dr. Du Jianming, while the non-executive directors include Mr. Peter Peace Tulloch, Ms. Guo Liqihua (Independent Non-Executive Director), Mr. Guan Qichang (Independent Non-Executive Director), Mr. Paul Joseph Tighe (Independent Non-Executive Director), and Mr. Luo Bishi (Independent Non-Executive Director).
CKLife Sciences Group will hold a board of directors meeting in Hong Kong on Tuesday, August 13, 2024. The main agenda of the meeting includes approving the release of the interim performance report for the six months ending June 30, 2024, and considering the distribution of interim dividends. The company's executive directors include Mr. Li Zeju (Chairman), Mr. Gan Qinglin, Mr. Ye Dequan, Mr. Yu Yingcai, and Dr. Du Jianming, while the non-executive directors include Mr. Peter Peace Tulloch, Ms. Guo Liqihua (Independent Non-Executive Director), Mr. Guan Qichang (Independent Non-Executive Director), Mr. Paul Joseph Tighe (Independent Non-Executive Director), and Mr. Luo Bishi (Independent Non-Executive Director).
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    JIUYUAN GENE
    02566
    -- 7.090
    PURAPHARM
    01498
    -- 0.570
    LEE'S PHARM
    00950
    -- 1.330
    NEP INTERLONG
    08329
    -- 0.160
    SIMCERE PHARMA
    02096
    -- 7.390
    Log In for the Full List
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
    Discussing
    Major earnings are approaching! What's ahead for Chinese stocks in 2025?
    Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
    Alibaba Group Q4 FY2024 earnings conference call